SCHEMBL15424140

SCHEMBL15424140

O=C(NO)c1ccc(C(=O)Nc2ccc(Cl)c(-c3nc4ccccc4[nH]3)c2)cc1

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.73
▸ KMT2A Q03164 3/20 0.73
▸ HTT P42858 2/20 0.73
▸ MAPT P10636 3/20 0.71
▸ KDM4E B2RXH2 2/20 0.71
▸ ALDH1A1 P00352 1/20 0.71
▸ ADORA2A P29274 1/20 0.64
▸ TP53 P04637 1/20 0.63
▸ RXFP1 Q9HBX9 1/20 0.63
▸ HPSE Q9Y251 1/20 0.61
▸ NPC1 O15118 1/20 0.60
▸ POLB P06746 1/20 0.60
▸ THRB P10828 1/20 0.60
▸ RECQL P46063 1/20 0.60
▸ RAB9A P51151 1/20 0.60
▸ ATM Q13315 1/20 0.60
▸ MMP2 P08253 1/20 0.58
▸ MMP9 P14780 1/20 0.58
▸ MMP8 P22894 1/20 0.58
▸ MMP13 P45452 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15424138 0.94 MAPT (0.75) MEN1KMT2AHTTMAPTKDM4E
SCHEMBL20145790 0.92 MEN1 (0.62) MEN1KMT2AHTTMAPTKDM4E
SCHEMBL15558259 0.90 MEN1 (0.71) MEN1KMT2AHTTMAPTKDM4E
SCHEMBL14642442 0.89 MEN1 (0.79) MEN1KMT2AHTTMAPTKDM4E
SCHEMBL15424155 0.89 MEN1 (0.67) MEN1KMT2AHTTMAPTKDM4E
SCHEMBL15424144 0.88 MEN1 (0.64) MEN1KMT2AHTTMAPTKDM4E
SCHEMBL13679611 0.88 MEN1 (0.74) MEN1KMT2AHTTMAPTKDM4E
SCHEMBL13679601 0.88 MAPT (0.82) MEN1KMT2AHTTMAPTKDM4E
SCHEMBL15557984 0.88 MEN1 (0.68) MEN1KMT2AHTTMAPTKDM4E
SCHEMBL15557427 0.86 MEN1 (0.75) MEN1KMT2AHTTMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170349573-A1 HEDGEHOG ANTAGONISTS HAVING ZINC BINDING MOIETIES CURIS INC (US) 2017-12-07 — — US disclosed
US-9708299-B2 Hedgehog antagonists having zinc binding moieties GENENTECH, INC. (US) 2017-07-18 — — US disclosed
US-9708299-B2 Hedgehog antagonists having zinc binding moieties GENENTECH, INC. (US) 2017-07-18 — — US disclosed
US-20140018368-A1 HEDGEHOG ANTAGONISTS HAVING ZINC BINDING MOIETIES GENETECH, INC. (US) 2014-01-16 — — US disclosed
US-20140018368-A1 HEDGEHOG ANTAGONISTS HAVING ZINC BINDING MOIETIES GENETECH, INC. (US) 2014-01-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170349573-A1 HEDGEHOG ANTAGONISTS HAVING ZINC BINDING MOIETIES GLI1, SHH, HDAC1 MEN1 3364/4885KMT2A 126/4885HTT 1409/4885
US-20140018368-A1 HEDGEHOG ANTAGONISTS HAVING ZINC BINDING MOIETIES GLI1, SHH, HDAC1 MEN1 3364/4885KMT2A 126/4885HTT 1409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback